Home » Disorders » Depression » New Study of DBS for Depression

New Study of DBS for Depression

brainResearchers report the initiation of a double-blind study assessing the efficacy of deep brain stimulation for individuals who suffer from major depression.

The study, called BROADEN(TM) (BROdmann Area 25 DEep brain Neuromodulation), is a controlled, multi-site, blinded study that is evaluating the safety and effectiveness of DBS in patients with depression for whom currently available treatments are not effective.

“We are excited to be part of the first double-blind study of Deep Brain Stimulation for depression and remain hopeful that this therapy may prove beneficial for this seriously ill patient population,” said Anthony D’Agostino, M.D., medical director of Alexian Brothers Behavioral Health Hospital and the principal investigator at the study site.

“The study is an important contribution to the advancement of treatment options for severely depressed patients.”

This study is researching a specific area in the brain called Brodmann Area 25 that is thought to be involved in depression.

The first research of DBS for depression was conducted in Toronto, Canada, by neurologist Helen S. Mayberg, M.D., and neurosurgeon Andres Lozano, M.D., in 2003.

They published their findings in Neuron in March 2005, reporting that brain imaging studies indicate that Brodmann Area 25 appears to be overactive in profoundly sad and depressed people.

St. Jude Medical owns the intellectual property rights, and has various patents issued and pending, for the use of neurostimulation at Brodmann Area 25. The Libra Deep Brain Stimulation System provides mild pulses of current from a device implanted near the collarbone and connected to small electrical leads placed at specific targets in the brain.

“This depression study represents a continuation of our commitment to provide solutions for those who are suffering and in need of additional therapy options,” said Chris Chavez, president of the St. Jude Medical ANS Division.

“The Brodmann Area 25 study is an important step in bringing physicians and their patients a neuromodulation therapy that, if successful, will treat this debilitating form of depression.”

The National Institute of Mental Health estimates that more than 21 million U.S. adults suffer from some kind of depressive disorder. Current therapies are effective for about 80 percent of this patient population according to the National Advisory Mental Health Council. That means approximately 4 million adult Americans live with depression that doesn’t respond to medications, psychotherapy or electroconvulsive therapy.

Source: St. Jude Medical

New Study of DBS for Depression

Rick Nauert PhD

Rick Nauert, PhDDr. Rick Nauert has over 25 years experience in clinical, administrative and academic healthcare. He is currently an associate professor for Rocky Mountain University of Health Professionals doctoral program in health promotion and wellness. Dr. Nauert began his career as a clinical physical therapist and served as a regional manager for a publicly traded multidisciplinary rehabilitation agency for 12 years. He has masters degrees in health-fitness management and healthcare administration and a doctoral degree from The University of Texas at Austin focused on health care informatics, health administration, health education and health policy. His research efforts included the area of telehealth with a specialty in disease management.

APA Reference
Nauert PhD, R. (2015). New Study of DBS for Depression. Psych Central. Retrieved on June 20, 2018, from https://psychcentral.com/news/2008/06/27/new-study-of-dbs-for-depression/2518.html

 

Scientifically Reviewed
Last updated: 6 Oct 2015
Last reviewed: By John M. Grohol, Psy.D. on 6 Oct 2015
Published on PsychCentral.com. All rights reserved.